EMEA Electronic Colposcope market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

EMEA Electronic Colposcope market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

The electronic colposcope market in Europe, Middle East, and Africa (EMEA) is projected to attain significant earnings by 2022, according to a report on Radiant Insights, Inc. It is estimated to expand at a significant growth rate from 2012 to 2022 (forecast period).

Colposcopy is a medical procedure to examine the cervix using an electronic or binocular colposcope. Electronic colposcopes are medical tools designed to provide colposcopists an enlarged view of the tissues in the vulva and vagina. It is mainly used to detect precancer lesions and identify the presence of abnormal tissues.

High prevalence of cervical cancer is expected to be the major driver of the market. Change in lifestyles, evolution of screening technology, and programs to create awareness regarding these devices among women are factors estimated to influence market growth.

Introduction of cervical screening tests in South Africa and surrounding countries is expected to affect electronic colposcope sales. In addition, implementation of new technologies that keep an online database of family medical histories can assist in prevention of cervical cancer.

Prevalence of human papillomavirus (HPV) in African countries is another factor that can influence sales in EMEA. Need for instruments that can catch signs of lesions in the cervix has led to continuous improvement in electronic colposcopes. Dysis Medical, one of the key market participants, has launched Smart Colposcopy, which can reproduce an accurate image of the cervix and its internal areas in a higher resolution. It can also be used to detect various chronic gynecologic conditions.

The electronic colposcope market in EMEA is segmented by type, end user, and region. By type, the market is bifurcated into desktop and handheld colposcopes. Major market end users include clinics and hospitals.

Regions covered in the EMEA market report are Europe, Africa, and the Middle East. The Middle East market is projected to witness massive growth due to rising incidence of cervical cancer among women. Awareness campaigns by doctors in Saudi Arabia and Dubai to promote annual testing of the cervix may provide scope for the market. The Africa market also possesses potential for high growth due to lack of testing methods for HPV in rural areas.

The Europe market is anticipated to grow exponentially till 2022 due to development of new technologies to be used in addition to colposcopy equipment for clear cervix examination. Sale of cost-effective systems in Benelux and Scandinavia may contribute to regional market growth. Manufacturers in the region are also conducting experiments in rural areas. An instance of this is Gynius AB, a Swedish medical device manufacturer that designed Gynocular TM, a portable electronic colposcope. It was used to diagnose cancerous cervical lesions in India and recommend appropriate treatment.

Prominent market players include Zeiss; LEISEGANG Feinmechanik-Optik GmbH; Dysis Medical; ATMOS MedizinTechnik; and Seiler Instrument Inc. These players are focusing on improving their current products to assist colposcopists in their examinations. Efforts taken by companies to eradicate cervical cancer by providing mobile colposcopy services in rural areas of Africa and the Middle East may usher in lucrative returns for the electronic colposcope market in EMEA.